Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Cholangiocarcinoma 2Pancreatic Neoplasms 1Klatskin Tumor 1Gastrointestinal Neoplasms 1Gallbladder Neoplasms 1Disease 1

Interventions

Oxaliplatin 6Fluorouracil 6Leucovorin 4Capecitabine 4Blood Specimen Collection 4Pafolacianine 3Cisplatin 3Cetuximab 3Bevacizumab 3pembrolizumab 2atezolizumab 2XELOX 2Surveys and Questionnaires 2Standard of Care 2Specimen Handling 2Paclitaxel 2Irinotecan 2IDRX-42 2Gemcitabine 2Folfox protocol 2Endoscopic Mucosal Resection 2Drug Therapy 2Docetaxel 2Carboplatin 2130-nm albumin-bound paclitaxel 2trastuzumab deruxtecan 1sodium thiosulfate 1sodium propionate 1sacituzumab govitecan 1s-formylglutathione hydrolase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Gastrointestinal Neoplasms × Cholangiopancreatography, Endoscopic Retrograde × Clear all
NCT05994521 2024-10-01

INTERCEPT

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase NA Recruiting
110 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡